Robin Gao

Robin joined Sixty Degree Capital in November 2019. Prior to joining, Robin worked for Toronto healthcare startups AmacaThera and Focal Healthcare in both business development and fundraising roles. Previously, Robin worked for ApoPharma’s pre-clinical research division as well as also performed HIV vaccines and MRI contrast agents research at the University of Toronto. Robin holds an MMI (Master of Management of Innovation) and H.B.Sc in Biological Chemistry from University of Toronto.